SCOT is an essential activity for Helicobacter pylori survival in vivo and a potential target for drug therapy.

被引：0
|
作者：
Bergonzelli, GE
Haas, R
Bachmann, D
Blum, AL
CorthesyTheulaz, IE
机构：
[1] CHU VAUDOIS, DIV GASTROENTEROL, LAUSANNE, SWITZERLAND
[2] MAX PLANCK INST, TUBINGEN, GERMANY
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A71 / A71
页数：1
相关论文
共 50 条
  • [1] The Helicobacter pylori ureI protein is not involved in urease activity but is essential for bacterial survival in vivo
    Skouloubris, S
    Thiberge, JM
    Labigne, A
    De Reuse, H
    INFECTION AND IMMUNITY, 1998, 66 (09) : 4517 - 4521
  • [2] SCOT genes and enzymatic activity are present in all Helicobacter pylori strains
    LeGurun, S
    Bergonzelli, GE
    Blum, AL
    CorthesyTheulaz, IE
    GASTROENTEROLOGY, 1997, 112 (04) : A197 - A197
  • [3] Helicobacter pylori eradication therapy.: The Spanish Consensus Report
    Gisbert, JP
    Calvet, X
    Gomollón, F
    Sáinz, R
    MEDICINA CLINICA, 2000, 114 (05): : 185 - 195
  • [4] Proximal migration of Helicobacter pylori and prolonged acid suppression therapy.
    Ihmaidat, H
    MacKay, CK
    Kasem, H
    Carter, CR
    Going, J
    Stuart, RC
    GASTROENTEROLOGY, 1997, 112 (04) : A155 - A155
  • [5] Usefulness of serology in determination of Helicobacter pylori eradication after therapy.
    Fallone, CA
    Barkun, AN
    Loo, V
    Hu, X
    GASTROENTEROLOGY, 1996, 110 (04) : A106 - A106
  • [6] The chances of Helicobacter pylori distribution after omeprazole and amoxicillin therapy.
    Lee, SJ
    Lee, YC
    Park, HJ
    Moon, YM
    Kang, JK
    Park, IS
    Kim, HK
    GASTROENTEROLOGY, 1998, 114 (04) : A198 - A198
  • [7] Single drug therapy for Helicobacter pylori infection
    Miskovitz, P
    Cooper, R
    Nagler, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10): : 2996 - 2996
  • [8] Therapy and drug resistance in Helicobacter pylori infection
    Bazzoli, F
    Olivieri, L
    De Luca, L
    Pozzato, P
    Lehours, P
    Mégrand, F
    DIGESTIVE AND LIVER DISEASE, 2000, 32 : S207 - S210
  • [9] Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease
    Pellicano, R.
    Peyre, S.
    Astegiano, M.
    Oliaro, E.
    Fagoonee, S.
    Rizzetto, M.
    PANMINERVA MEDICA, 2006, 48 (04) : 241 - 246
  • [10] Helicobacter pylori might be a potential therapeutic target in epilepsy
    Kountouras, Jannis
    Zavos, Christos
    Deretzi, Georgia
    Polyzos, Stergios A.
    Katsinelos, Panagiotis
    Anastasiadou, Kyriaki
    Stergiopoulos, Christos
    Pilpilidis, Ioannis
    Klonizakis, Philippos
    Boura, Panagiota
    Tzilves, Dimitrios
    MEDICAL HYPOTHESES, 2011, 76 (05) : 763 - 763
12345